Positron Corporation (POSC)

[Medtrade77]

CMS removes exclusion for non-oncologic PET

CMS published its CY 2022 MPFS Proposed Rule—including a significant change for nuclear medicine.
CMS proposes to remove the "exclusionary language" from Positron Emission Tomography (PET) Scans.

This will leave non-oncologic PET indications to the discretion of local Medicare Administrative Contractors (MACs).

CMS stated, "We believe that extending local contractor discretion for non-oncologic indications of PET provides an immediate avenue to potential coverage in appropriate candidates and provides a framework that better serves the needs of the Medicare program and its beneficiaries." New FDA-approved non-oncologic radiopharmaceuticals will be covered under MAC discretion.
We applaud CMS’s coverage decision, which results from years of work by SNMMI and our industry partners.